https://scholars.lib.ntu.edu.tw/handle/123456789/624043
標題: | Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment | 作者: | Chen, Ching-Tso Feng, Yin-Hsun Yen, Chia-Jui Chen, San-Chi Lin, Yun-Tzu LI-CHUN LU CHIH-HUNG HSU ANN-LII CHENG YU-YUN SHAO |
關鍵字: | Albumin-Bilirubin (ALBI) grade; Cancer of the Liver Italian Program (CLIP) score; Child–Pugh classification; Failure of Atezo-Bev treatment; Hepatocellular carcinoma; Liver function reserve; Prognosis; Second-line therapy; Systemic therapy; Treatment pattern | 公開日期: | 十月-2022 | 出版社: | SPRINGER | 卷: | 16 | 期: | 5 | 起(迄)頁: | 1199 | 來源出版物: | Hepatology international | 摘要: | The combination of atezolizumab and bevacizumab (Atezo-Bev) has become the standard first-line therapy for patients with advanced hepatocellular carcinoma (HCC), but the prognosis and treatment pattern after its treatment failure are unclear. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/624043 | ISSN: | 1936-0533 1936-0541 |
DOI: | 10.1007/s12072-022-10392-x |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。